Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 2/2021

01-02-2021 | Primary Immunodeficiency | Commentary

In Memoriam: Asghar Aghamohammadi (May 30, 1951–November 14, 2020)

Author: Nima Rezaei

Published in: Journal of Clinical Immunology | Issue 2/2021

Login to get access

Excerpt

Asghar Aghamohammadi, who I can name as the father of primary immunodeficiency diseases (PID) in Iran, passed away on November 14, 2020, at the age of 69. He died in Tehran, the capital of Iran, where he dedicated his life to providing the best care for PID patients, as well as to facilitating research and education in this field. He was a full professor of clinical immunology and allergy and the Head of the Research Center for Immunodeficiencies (RCID) at Tehran University of Medical Sciences. …
Literature
1.
2.
Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, et al. Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency. J Clin Immunol. 2020.
3.
Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020:1.
4.
5.
Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol. 2002;22(6):375–80.CrossRef
6.
Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, et al. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018;38(7):816–32.CrossRef
7.
Rezaei N, Notarangelo LD, Aghamohammadi A. Primary immunodeficiency diseases. Springer; 2008.
8.
Rezaei N, Aghamohammadi A, Notarangelo LD, Primary immunodeficiency diseases : definition, diagnosis, and management. 2017.
9.
Metadata
Title
In Memoriam: Asghar Aghamohammadi (May 30, 1951–November 14, 2020)
Author
Nima Rezaei
Publication date
01-02-2021
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00945-w

Other articles of this Issue 2/2021

Journal of Clinical Immunology 2/2021 Go to the issue

Original Article

The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19

Original Article

Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing

Letter to Editor

BCG-osis and Hematopoietic Cell Transplant for Primary Immunodeficiencies

Letter to Editor

Infection Due to Serratia sp. in Chronic Granulomatous Disease—Is the Incidence Low in Tropical Countries?

Letter to Editor

Functional Asplenia and Specific Polysaccharide Antibody Deficiency in a Girl with SAVI

Letter to Editor

Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits